Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS1 | Q07889 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9341658 | 0.82 | CYP2D6 (0.36) | CYP2D6CYP2C9KIF11 | |
| SCHEMBL5420882 | 0.78 | CA1 (0.37) | — | |
| SCHEMBL30975518 | 0.78 | CA1 (0.37) | — | |
| SCHEMBL6731777 | 0.78 | MEN1 (0.33) | CYP2D6CYP2C9KIF11 | |
| SCHEMBL6725109 | 0.74 | — | — | |
| SCHEMBL31422660 | 0.73 | ERN1 (0.42) | — | |
| SCHEMBL27097096 | 0.72 | CYP2D6 (0.35) | CYP2D6CYP2C9KIF11 | |
| SCHEMBL20817245 | 0.71 | SOS1 (0.31) | SOS1 | |
| SCHEMBL7932559 | 0.71 | CA1 (0.34) | CYP2D6CYP2C9KIF11 | |
| SCHEMBL22122630 | 0.71 | CYP3A4 (0.36) | SOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6677479-B2 | REACTING A HALOGENATED BENZENE COMPOUND WITH ALDEHYDE; SOLVENT EXTRACTION; PURIFICATION | CLARIANT FINANCE LBVI LIMITED (VG) | 2004-01-13 | — | — | US | disclosed |
| US-20030092930-A1 | Substituted fluoroaromatics, process for preparing them and their use | CLARIANT GMBH | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092930-A1 | Substituted fluoroaromatics, process for preparing them and their use | CYP2F1, CYP1A1, CYP4X1 | SOS1 1171/4885CYP2D6 24/4885CYP2C9 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.